Last reviewed · How we verify
NCT04370444
Pathways for Patient-centered Diagnosis and Management of Endometriosis-associated Deep Dyspareunia
NA trial testing Phallus Length Reducer in Endometriosis-related Pain in 30 participants. Completed in 31 December 2021.
31 October 2021
Quick facts
| Lead sponsor | BC Women's Hospital & Health Centre |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 10 March 2021 |
| Primary completion | 31 October 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Phallus Length Reducer
- Self-assessment of dyspareunia
Conditions studied
- Endometriosis-related Pain — all drugs for Endometriosis-related Pain →
- Dyspareunia Deep — all drugs for Dyspareunia Deep →
Sponsor
BC Women's Hospital & Health Centre
Who can join
Adults 19 to 49, any sex, with Endometriosis-related Pain or Dyspareunia Deep. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the acceptability and effectiveness of two tools that may help address the management of deep dyspareunia: 1) A phallus length reducer (PLR, brand name: Ohnut), consisting of 4 interconnected silicone rings worn externally over the penetrating object to reduce pain with deep penetration by allowing adjustable limitation of penetration depth, and 2) A vaginal insert for at home self-assessment of the extent and severity of deep dyspareunia.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Ohnut Versus a Waitlist Control for the Self-management of Endometriosis-Associated Deep Dyspareunia: Protocol for a Pilot Randomized Controlled Trial.
Zhang SXJ, MacLeod RGK, Parmar G, Orr NL, et al · · 2023 · cited 5× · PMID 36972117 · DOI 10.2196/39834 -
Ohnut vs waitlist control for the self-management of endometriosis-associated deep dyspareunia: a pilot randomized controlled trial.
Wahl K, Orr NL, Parmar G, Zhang SXJ, et al · · 2024 · cited 2× · PMID 39220343 · DOI 10.1093/sexmed/qfae049
Verify or expand the search:
- PubMed search for NCT04370444
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endometriosis-related Pain
Currently open trials in the same condition.
- NCT06963177 — A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometrio · Phase 2 · recruiting
- NCT06795243 — Efficacy of Physical Therapy Treatment in Endometriosis and Its Relationship to Adherence Rates. · NA · recruiting
- NCT06414083 — Histologic Comparison of Ablative Techniques for Endometriosis · NA · recruiting
- NCT05978414 — Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology · NA · recruiting
- NCT05754190 — Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA · recruiting
Other BC Women's Hospital & Health Centre trials
Trials by the same sponsor.
- NCT06215937 — Quantitative Sensory Testing and Central Sensitization in Endometriosis · recruiting
- NCT06217315 — Endometriosis and Health Care System Utilization in British Columbia · active not recruiting
- NCT04840329 — Endocation: Trial of an Endometriosis Education Program · NA · completed
- NCT03216330 — Dyspareunia and Central Sensitization · completed
- NCT03409653 — Complex Chronic Diseases Program Data Registry · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04370444 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BC Women's Hospital & Health Centre
- Last refreshed: 18 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04370444.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing